Free Trial

Veeco Instruments (VECO) Financials

Veeco Instruments logo
$19.20 -0.23 (-1.18%)
Closing price 05/23/2025 04:00 PM Eastern
Extended Trading
$19.19 -0.01 (-0.05%)
As of 05/23/2025 04:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Veeco Instruments

Annual Income Statements for Veeco Instruments

This table shows Veeco Instruments' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Income / (Loss) Attributable to Common Shareholders
74 -30 167 26 -8.39 -79 -407 -51 -122 -32 -67
Consolidated Net Income / (Loss)
74 -30 167 26 -8.39 -79 -407 -51 -122 -32 -67
Net Income / (Loss) Continuing Operations
74 -30 167 26 -8.39 -79 -407 -51 -122 -32 -67
Total Pre-Tax Income
69 -28 51 26 -8.46 -78 -434 -89 -119 -23 -78
Total Operating Income
67 70 60 57 23 -40 -416 -72 -120 -23 -79
Total Gross Profit
304 285 263 242 194 158 194 176 133 177 135
Total Revenue
717 666 646 583 454 419 542 476 332 477 393
Operating Revenue
717 666 646 583 454 419 542 476 332 477 393
Total Cost of Revenue
413 381 383 341 260 261 348 299 199 300 258
Operating Cost of Revenue
413 381 383 341 260 261 348 299 199 300 258
Total Operating Expenses
237 215 203 186 172 198 609 248 253 200 214
Selling, General & Admin Expense
100 93 89 85 76 80 92 100 78 90 90
Research & Development Expense
125 113 104 89 79 91 98 82 81 79 81
Amortization Expense
6.98 8.48 10 12 15 17 32 35 19 28 13
Other Operating Expenses / (Income)
-22 1.03 0.32 0.07 -0.22 -0.04 0.37 -0.39 0.22 -0.70 -3.18
Impairment Charge
28 0.00 0.00 - 0.28 4.02 375 1.14 70 0.13 58
Total Other Income / (Expense), net
1.85 -98 -9.31 -31 -31 -38 -18 -17 0.96 0.59 0.86
Interest Expense
11 12 12 28 25 22 22 19 0.22 0.46 0.72
Interest & Investment Income
13 11 2.20 2.34 1.55 4.68 3.19 2.34 1.18 1.05 1.57
Other Income / (Expense), net
0.00 -97 0.00 -5.01 -7.84 -21 0.00 - - - -
Income Tax Expense
-4.88 2.03 -116 -0.36 -0.07 0.78 -27 -38 2.82 9.33 -11
Basic Earnings per Share
$1.31 ($0.56) $3.35 $0.53 ($0.17) ($1.66) ($8.63) ($1.16) ($3.10) ($0.80) ($1.70)
Weighted Average Basic Shares Outstanding
56.43M 53.77M 49.91M 49.07M 48.36M 47.48M 47.15M 44.17M 39.34M 39.74M 39.35M
Diluted Earnings per Share
$1.23 ($0.56) $2.71 $0.49 ($0.17) ($1.66) ($8.63) ($1.16) ($3.10) ($0.80) ($1.70)
Weighted Average Diluted Shares Outstanding
61.60M 53.77M 65.61M 53.64M 48.36M 47.48M 47.15M 44.17M 39.34M 39.74M 39.35M
Weighted Average Basic & Diluted Shares Outstanding
57.94M 56.37M 51.66M 50.65M 49.72M 49.00M 47.20M 44.30M 39.30M 40M 39.40M

Quarterly Income Statements for Veeco Instruments

This table shows Veeco Instruments' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Income / (Loss) Attributable to Common Shareholders
12 15 22 15 22 22 25 -85 8.74 129 15
Consolidated Net Income / (Loss)
12 15 22 15 22 22 25 -85 8.74 129 15
Net Income / (Loss) Continuing Operations
12 15 22 15 22 22 25 -85 8.74 129 15
Total Pre-Tax Income
15 4.36 25 17 23 24 23 -84 9.00 12 15
Total Operating Income
14 3.88 24 17 22 24 22 14 9.81 13 18
Total Gross Profit
68 74 79 75 75 79 77 68 62 63 70
Total Revenue
167 182 185 176 174 174 177 162 154 154 172
Operating Revenue
167 182 185 176 174 174 177 162 154 154 172
Total Cost of Revenue
99 108 106 100 99 95 100 94 91 91 102
Operating Cost of Revenue
99 108 106 100 99 95 100 94 91 91 102
Total Operating Expenses
54 70 55 59 53 54 55 54 52 50 52
Selling, General & Admin Expense
25 25 25 25 25 23 23 24 23 21 22
Research & Development Expense
29 31 32 32 30 29 29 27 28 26 27
Amortization Expense
0.82 1.58 1.69 1.83 1.89 2.12 2.12 2.12 2.11 2.50 2.51
Other Operating Expenses / (Income)
-0.04 -16 -4.32 0.55 -2.86 -0.24 0.86 0.49 -0.09 -0.27 0.63
Total Other Income / (Expense), net
0.84 0.48 0.32 0.35 0.71 - 0.25 -98 -0.80 -1.56 -2.32
Interest Expense
2.51 2.78 2.88 2.77 2.62 3.07 2.78 3.05 2.88 2.88 2.89
Interest & Investment Income
3.34 3.26 3.20 3.12 3.32 3.07 3.02 2.42 2.07 1.33 0.57
Income Tax Expense
3.04 -11 2.71 2.13 0.90 2.55 -2.06 1.29 0.26 -117 0.21
Basic Earnings per Share
$0.21 $0.26 $0.39 $0.27 $0.39 $0.44 $0.44 ($1.61) $0.17 $2.59 $0.30
Weighted Average Basic Shares Outstanding
57.75M 56.43M 56.41M 56.28M 55.97M 53.77M 55.35M 52.86M 50.56M 49.91M 49.89M
Diluted Earnings per Share
$0.20 $0.25 $0.36 $0.25 $0.37 $0.46 $0.42 ($1.61) $0.17 $2.02 $0.27
Weighted Average Diluted Shares Outstanding
60.23M 61.60M 62.65M 62.54M 60.76M 53.77M 59.64M 52.86M 59.86M 65.61M 65.15M
Weighted Average Basic & Diluted Shares Outstanding
58.29M 57.94M 56.78M 56.78M 56.64M 56.37M 56.34M 56.35M 51.69M 51.66M 51.43M

Annual Cash Flow Statements for Veeco Instruments

This table details how cash moves in and out of Veeco Instruments' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Net Change in Cash & Equivalents
-13 3.65 35 -9.81 0.33 -83 -67 3.10 8.23 -1.58 60
Net Cash From Operating Activities
64 62 108 68 43 -7.42 -38 35 -24 16 42
Net Cash From Continuing Operating Activities
64 62 108 68 43 -7.42 -38 35 -24 16 42
Net Income / (Loss) Continuing Operations
74 -30 167 26 -8.39 -79 -407 -51 -122 -32 -67
Consolidated Net Income / (Loss)
74 -30 167 26 -8.39 -79 -407 -51 -122 -32 -67
Depreciation Expense
25 25 26 26 31 34 50 50 33 40 25
Amortization Expense
1.26 1.12 0.96 14 14 13 12 10 - - -
Non-Cash Adjustments To Reconcile Net Income
4.82 130 74 -11 -9.40 46 413 36 76 17 70
Changes in Operating Assets and Liabilities, net
-41 -64 -159 12 16 -22 -105 -10 -11 -8.98 14
Net Cash From Investing Activities
-65 -53 -69 45 -72 -76 -18 -358 47 -7.08 8.10
Net Cash From Continuing Investing Activities
-65 -53 -69 45 -72 -76 -18 -358 47 -7.08 8.10
Purchase of Property, Plant & Equipment
-18 -28 -25 -41 -6.80 -11 -13 -24 -11 -14 -16
Acquisitions
0.00 -30 0.00 0.00 - - -2.66 -402 - -0.07 -144
Purchase of Investments
-203 -178 -104 -247 -248 -193 -93 -283 -103 -86 -160
Sale of Property, Plant & Equipment
2.03 0.00 0.00 1.73 9.50 0.65 0.00 2.28 9.51 3.07 9.26
Sale and/or Maturity of Investments
154 183 60 331 174 127 90 349 152 89 318
Net Cash From Financing Activities
-13 -4.68 -4.55 -122 29 0.13 -11 326 -15 -10 9.69
Net Cash From Continuing Financing Activities
-13 -4.68 -4.55 -122 29 0.13 -11 326 -15 -10 9.69
Repayment of Debt
0.00 -219 0.00 -116 -81 0.00 0.00 -1.19 -0.34 -0.31 -0.29
Issuance of Debt
0.00 223 0.00 0.00 120 0.00 0.00 336 - - -
Issuance of Common Equity
5.30 4.62 3.70 3.40 2.88 3.11 3.06 2.99 1.66 2.23 -
Other Financing Activities, net
-18 -14 -8.25 -8.99 -13 -2.98 -3.07 -8.74 -2.60 -3.22 9.98
Effect of Exchange Rate Changes
0.01 -0.02 -0.05 -0.05 0.01 0.03 - - - -0.09 0.15
Cash Interest Paid
9.50 12 10 13 13 9.41 9.71 4.68 0.23 0.49 0.16
Cash Income Taxes Paid
3.03 5.10 1.43 -0.14 0.33 2.93 4.80 1.94 1.67 7.09 3.32

Quarterly Cash Flow Statements for Veeco Instruments

This table details how cash moves in and out of Veeco Instruments' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Net Change in Cash & Equivalents
29 -18 -11 0.13 15 2.32 -24 40 -14 -14 52
Net Cash From Operating Activities
20 28 18 8.46 9.36 29 7.05 11 14 33 47
Net Cash From Continuing Operating Activities
20 28 18 8.46 9.36 29 7.05 11 14 33 47
Net Income / (Loss) Continuing Operations
12 15 22 15 22 22 25 -85 8.74 129 15
Consolidated Net Income / (Loss)
12 15 22 15 22 22 25 -85 8.74 129 15
Depreciation Expense
5.04 5.98 6.15 6.60 6.41 6.35 6.18 6.16 6.28 6.55 6.35
Amortization Expense
0.26 0.32 0.32 0.32 0.30 0.29 0.31 0.29 0.23 0.24 0.24
Non-Cash Adjustments To Reconcile Net Income
-13 14 16 5.01 -30 21 -23 116 16 102 -22
Changes in Operating Assets and Liabilities, net
15 -6.68 -26 -18 10 -20 -1.15 -26 -17 -205 48
Net Cash From Investing Activities
15 -46 -30 -9.94 21 -26 -30 3.13 -0.76 -48 4.80
Net Cash From Continuing Investing Activities
15 -46 -30 -9.94 21 -26 -30 3.13 -0.76 -48 4.80
Purchase of Property, Plant & Equipment
-6.76 -5.18 -3.99 -2.95 -5.99 -11 -6.40 -3.89 -6.95 -2.83 -6.35
Purchase of Investments
-45 -78 -61 -35 -29 -67 -41 -66 -3.49 -60 -10
Sale of Property, Plant & Equipment
0.00 - - - 2.03 - - - 0.00 - -
Sale and/or Maturity of Investments
66 38 35 28 53 52 18 73 40 15 21
Net Cash From Financing Activities
-5.28 -0.25 0.90 1.62 -15 -1.05 -1.66 25 -27 0.36 0.08
Net Cash From Continuing Financing Activities
-5.28 -0.25 0.90 1.62 -15 -1.05 -1.66 25 -27 0.36 0.08
Repayment of Debt
0.00 - - - 0.00 - - -199 -20 - -
Issuance of Debt
0.00 - - - 0.00 - - 223 0.00 - -
Issuance of Common Equity
1.40 0.94 1.18 1.87 1.32 0.91 1.09 1.38 1.24 0.79 0.78
Other Financing Activities, net
-6.68 -1.19 -0.29 -0.25 -16 -1.96 -2.75 -0.29 -8.51 -0.43 -0.70
Effect of Exchange Rate Changes
0.01 -0.08 0.14 -0.00 -0.04 0.04 -0.01 -0.05 0.01 0.06 -0.06
Cash Interest Paid
0.71 4.02 0.80 4.06 0.62 4.49 0.67 3.88 2.74 2.38 2.72
Cash Income Taxes Paid
-1.67 0.07 0.44 1.54 0.99 1.23 0.88 2.60 0.39 0.09 0.27

Annual Balance Sheets for Veeco Instruments

This table presents Veeco Instruments' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Total Assets
1,252 1,229 1,128 899 898 818 901 1,387 759 891 929
Total Current Assets
765 706 669 549 587 476 520 597 502 542 556
Cash & Equivalents
146 159 155 120 130 129 212 280 277 269 271
Restricted Cash
0.22 0.34 0.55 0.73 0.66 0.66 0.81 0.85 - - 0.54
Short-Term Investments
199 147 147 104 190 115 48 48 67 116 121
Accounts Receivable
134 127 141 128 101 71 77 99 58 50 60
Inventories, net
247 238 207 171 146 133 156 120 77 77 61
Prepaid Expenses
39 35 18 26 19 15 22 33 16 23 23
Plant, Property, & Equipment, net
114 118 107 100 65 76 80 85 61 80 79
Total Noncurrent Assets
373 404 352 250 246 266 300 705 196 269 295
Goodwill
215 215 182 182 182 182 184 307 115 115 115
Intangible Assets
8.83 44 24 34 46 62 85 370 58 132 159
Noncurrent Deferred & Refundable Income Taxes
120 118 116 1.64 1.44 1.55 1.87 3.05 2.05 1.38 1.18
Other Noncurrent Operating Assets
29 27 30 32 16 21 29 25 21 21 20
Total Liabilities & Shareholders' Equity
1,252 1,229 1,128 899 898 818 901 1,387 759 891 929
Total Liabilities
481 557 550 461 490 444 463 547 164 176 191
Total Current Liabilities
192 218 258 189 147 118 160 224 144 162 168
Short-Term Debt
26 0.00 20 0.00 - - - - 0.37 0.34 0.31
Accounts Payable
44 42 52 44 34 21 40 50 23 30 18
Accrued Expenses
55 58 56 80 45 41 46 58 33 49 48
Current Deferred Revenue
65 118 127 63 67 55 73 112 85 76 96
Current Deferred & Payable Income Tax Liabilities
2.09 0.00 2.43 1.86 0.91 0.83 1.26 3.85 2.31 6.21 5.56
Total Noncurrent Liabilities
289 339 292 272 343 325 303 323 20 14 22
Long-Term Debt
250 275 254 229 321 300 287 276 0.83 1.19 1.53
Noncurrent Deferred & Payable Income Tax Liabilities
0.69 6.55 1.29 4.79 5.24 5.65 5.69 37 13 11 16
Other Noncurrent Operating Liabilities
38 57 37 38 17 20 9.91 11 6.40 1.54 4.19
Total Equity & Noncontrolling Interests
771 672 578 438 408 375 438 840 595 715 739
Total Preferred & Common Equity
771 672 578 438 408 375 438 840 595 715 739
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
771 672 578 438 408 375 438 840 595 715 739
Common Stock
1,228 1,203 1,079 1,117 1,114 1,072 1,062 1,052 764 768 751
Retained Earnings
-458 -532 -502 -681 -707 -699 -620 -213 -169 -45 -13
Accumulated Other Comprehensive Income / (Loss)
1.52 1.61 0.93 1.48 1.85 1.89 1.82 1.81 1.78 1.35 1.47

Quarterly Balance Sheets for Veeco Instruments

This table presents Veeco Instruments' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 3/31/2025 9/30/2024 6/30/2024 3/31/2024 9/30/2023 6/30/2023 3/31/2023 9/30/2022
Total Assets
1,279 1,273 1,235 1,234 1,246 1,228 1,167 997
Total Current Assets
795 761 718 716 721 709 643 650
Cash & Equivalents
175 163 174 174 156 181 141 169
Restricted Cash
0.17 0.26 0.29 0.33 0.38 0.44 0.48 0.56
Short-Term Investments
178 158 131 123 130 106 112 102
Accounts Receivable
148 163 132 141 152 151 138 173
Inventories, net
254 242 245 243 252 244 226 188
Prepaid Expenses
39 35 36 35 30 27 26 18
Plant, Property, & Equipment, net
114 113 113 115 118 112 113 108
Total Noncurrent Assets
370 399 403 403 407 407 411 238
Goodwill
215 215 215 215 215 215 215 182
Intangible Assets
8.01 39 40 42 46 48 50 26
Noncurrent Deferred & Refundable Income Taxes
119 116 118 119 118 115 116 1.64
Other Noncurrent Operating Assets
29 30 30 27 28 29 30 29
Total Liabilities & Shareholders' Equity
1,279 1,273 1,235 1,234 1,246 1,228 1,167 997
Total Liabilities
467 526 520 546 602 616 582 556
Total Current Liabilities
179 215 204 234 268 282 267 260
Short-Term Debt
0.00 26 26 26 0.00 0.00 0.00 20
Accounts Payable
58 50 47 54 63 63 62 51
Accrued Expenses
62 57 50 59 66 62 69 65
Current Deferred Revenue
57 80 81 94 139 157 133 122
Current Deferred & Payable Income Tax Liabilities
1.55 1.06 - 0.85 0.48 0.56 2.53 1.57
Total Noncurrent Liabilities
288 311 316 311 334 334 315 295
Long-Term Debt
250 249 249 249 275 274 255 254
Noncurrent Deferred & Payable Income Tax Liabilities
0.66 6.38 6.45 6.50 6.87 6.88 6.94 4.75
Other Noncurrent Operating Liabilities
37 55 61 56 52 52 53 36
Total Equity & Noncontrolling Interests
812 747 715 688 644 613 586 441
Total Preferred & Common Equity
812 747 715 688 644 613 586 441
Preferred Stock
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
812 747 715 688 644 613 586 441
Common Stock
1,257 1,218 1,209 1,197 1,197 1,190 1,077 1,072
Retained Earnings
-447 -473 -495 -510 -554 -578 -493 -631
Accumulated Other Comprehensive Income / (Loss)
1.63 1.85 1.47 1.48 1.50 1.37 1.40 0.22

Annual Metrics And Ratios for Veeco Instruments

This table displays calculated financial ratios and metrics derived from Veeco Instruments' official financial filings.

Metric 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Period end date 12/31/2024 12/31/2023 12/31/2022 12/31/2021 12/31/2020 12/31/2019 12/31/2018 12/31/2017 12/31/2016 12/31/2015 12/31/2014
Growth Metrics
- - - - - - - - - - -
Revenue Growth
7.63% 3.14% 10.78% 28.43% 8.30% -22.64% 13.96% 43.41% -30.47% 21.42% 18.42%
EBITDA Growth
8,851.73% -101.23% -5.10% 54.66% 539.40% 96.19% -3,023.00% 87.06% -626.61% 130.42% -2.34%
EBIT Growth
346.70% -145.03% 16.63% 251.13% 124.32% 85.43% -478.15% 40.19% -417.23% 70.67% -10.30%
NOPAT Growth
46.51% -75.20% 243.35% 264.03% 157.01% 90.47% -478.15% 40.19% -417.23% 70.67% -10.30%
Net Income Growth
342.74% -118.19% 541.15% 410.31% 89.34% 80.66% -692.06% 57.88% -281.60% 52.23% -58.39%
EPS Growth
319.64% -120.66% 453.06% 388.24% 89.76% 80.76% -643.97% 62.58% -287.50% 52.94% -55.96%
Operating Cash Flow Growth
3.47% -43.15% 60.14% 57.46% 680.11% 80.35% -207.84% 246.76% -251.02% -62.47% 5,686.66%
Free Cash Flow Firm Growth
125.28% -147.74% 268.31% -0.14% 36.47% -44.82% 105.56% -5,877.42% -1,445.79% 100.66% -8.04%
Invested Capital Growth
9.48% 16.76% 24.21% 8.05% -2.10% -9.85% -41.08% 212.99% -22.80% -4.96% 19.34%
Revenue Q/Q Growth
1.16% 3.11% 0.13% 2.46% 6.01% 3.51% -6.98% 10.91% -3.96% -1.45% 11.45%
EBITDA Q/Q Growth
-18.10% -101.25% -7.38% 0.34% 17.91% 89.18% -60.03% 50.45% 2.89% 141.38% -109.52%
EBIT Q/Q Growth
-23.26% -145.90% -6.56% 4.05% 188.88% 64.73% -42.54% -16.30% 4.03% 70.16% -58.19%
NOPAT Q/Q Growth
-9.36% 18.24% 204.22% 18.50% 342.71% 76.95% -42.54% -16.30% 4.03% 70.16% -58.19%
Net Income Q/Q Growth
-8.30% -139.48% 261.12% 46.83% 79.61% 58.68% -50.28% -7.68% 3.92% 59.57% -108.45%
EPS Q/Q Growth
-14.58% -156.00% 222.62% 44.12% 80.00% 59.11% -50.09% -9.43% 4.32% 60.00% -107.32%
Operating Cash Flow Q/Q Growth
-1.69% -5.55% 17.32% 2.52% -0.37% 65.29% -91.94% 122.32% 21.49% -77.61% 501.31%
Free Cash Flow Firm Q/Q Growth
9.25% 70.63% 74.12% -7.89% -60.49% 119.14% 1,231.75% 0.90% 25.46% 100.98% 1.33%
Invested Capital Q/Q Growth
0.15% 1.48% 23.77% 2.65% 0.09% -10.58% -22.17% -1.24% 1.01% 0.72% 12.80%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
42.38% 42.77% 40.73% 41.54% 42.78% 37.72% 35.74% 37.05% 40.13% 37.15% 34.33%
EBITDA Margin
13.02% -0.16% 13.45% 15.70% 13.04% -3.21% -65.26% -2.38% -26.38% 3.48% -13.91%
Operating Margin
9.34% 10.49% 9.33% 9.72% 4.97% -9.44% -76.65% -15.11% -36.23% -4.87% -20.16%
EBIT Margin
9.34% -4.07% 9.33% 8.86% 3.24% -14.44% -76.65% -15.11% -36.23% -4.87% -20.16%
Profit (Net Income) Margin
10.28% -4.56% 25.84% 4.46% -1.85% -18.78% -75.10% -10.80% -36.79% -6.70% -17.04%
Tax Burden Percent
107.09% 107.16% 327.43% 101.39% 99.14% 101.00% 93.84% 57.75% 102.37% 141.21% 85.43%
Interest Burden Percent
102.77% 104.37% 84.56% 49.67% -57.48% 128.74% 104.41% 123.82% 99.20% 97.48% 98.92%
Effective Tax Rate
-7.09% 0.00% -227.43% -1.39% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)
10.67% 8.22% 39.81% 13.50% 3.82% -6.28% -46.49% -9.68% -29.13% -4.86% -17.60%
ROIC Less NNEP Spread (ROIC-NNEP)
6.67% 276.47% 299.11% -1,062.88% -104.29% -152.48% 827.08% -9.13% -18.77% -0.86% -15.01%
Return on Net Nonoperating Assets (RNNOA)
-0.46% -13.08% -6.93% -7.34% -5.96% -13.10% -17.22% 2.52% 10.49% 0.46% 8.79%
Return on Equity (ROE)
10.22% -4.86% 32.88% 6.16% -2.14% -19.39% -63.71% -7.16% -18.64% -4.40% -8.81%
Cash Return on Invested Capital (CROIC)
1.62% -7.24% 18.21% 5.76% 5.93% 4.08% 5.21% -112.83% -3.40% 0.22% -35.23%
Operating Return on Assets (OROA)
5.40% -2.30% 5.95% 5.75% 1.72% -7.05% -36.32% -6.70% -14.57% -2.55% -8.44%
Return on Assets (ROA)
5.94% -2.58% 16.47% 2.90% -0.98% -9.16% -35.58% -4.79% -14.80% -3.51% -7.13%
Return on Common Equity (ROCE)
10.22% -4.86% 32.88% 6.16% -2.14% -19.39% -63.71% -7.16% -18.64% -4.40% -8.81%
Return on Equity Simple (ROE_SIMPLE)
9.56% -4.52% 28.89% 5.95% -2.05% -21.02% -92.99% -6.12% -20.52% -4.47% -9.06%
Net Operating Profit after Tax (NOPAT)
72 49 197 58 16 -28 -291 -50 -84 -16 -55
NOPAT Margin
10.00% 7.35% 30.56% 9.86% 3.48% -6.61% -53.65% -10.58% -25.36% -3.41% -14.11%
Net Nonoperating Expense Percent (NNEP)
4.00% -268.25% -259.30% 1,076.38% 108.11% 146.20% -873.57% -0.55% -10.36% -4.00% -2.59%
Return On Investment Capital (ROIC_SIMPLE)
6.85% 5.17% 23.16% - - - - - - - -
Cost of Revenue to Revenue
57.62% 57.23% 59.27% 58.46% 57.22% 62.28% 64.26% 62.95% 59.87% 62.85% 65.67%
SG&A Expenses to Revenue
13.89% 13.92% 13.77% 14.49% 16.79% 19.02% 16.98% 21.07% 23.41% 18.91% 22.85%
R&D to Revenue
17.36% 16.93% 16.03% 15.20% 17.39% 21.59% 18.03% 17.24% 24.42% 16.46% 20.66%
Operating Expenses to Revenue
33.04% 32.28% 31.39% 31.81% 37.81% 47.16% 112.39% 52.16% 76.35% 42.02% 54.49%
Earnings before Interest and Taxes (EBIT)
67 -27 60 52 15 -61 -416 -72 -120 -23 -79
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
93 -1.07 87 92 59 -13 -354 -11 -88 17 -55
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.97 2.60 1.65 3.29 2.11 1.92 0.81 0.85 1.99 1.18 1.90
Price to Tangible Book Value (P/TBV)
2.78 4.23 2.57 6.48 4.78 5.48 2.10 4.40 2.81 1.80 3.02
Price to Revenue (P/Rev)
2.12 2.62 1.48 2.47 1.90 1.71 0.65 1.51 3.57 1.76 3.57
Price to Earnings (P/E)
20.64 0.00 5.72 55.22 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
4.84% 0.00% 17.47% 1.81% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
2.07 2.68 1.69 3.26 2.11 1.85 0.82 0.84 3.34 1.41 2.95
Enterprise Value to Revenue (EV/Rev)
2.03 2.58 1.44 2.47 1.90 1.84 0.70 1.40 2.53 0.96 2.58
Enterprise Value to EBITDA (EV/EBITDA)
15.56 0.00 10.67 15.75 14.56 0.00 0.00 0.00 0.00 27.56 0.00
Enterprise Value to EBIT (EV/EBIT)
21.70 0.00 15.38 27.90 58.57 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
20.26 35.08 4.70 25.09 54.59 0.00 0.00 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
22.77 27.85 8.55 21.30 20.04 0.00 0.00 18.99 0.00 29.01 24.07
Enterprise Value to Free Cash Flow (EV/FCFF)
133.35 0.00 10.27 58.83 35.11 42.96 11.66 0.00 0.00 628.66 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.36 0.41 0.48 0.52 0.79 0.80 0.66 0.33 0.00 0.00 0.00
Long-Term Debt to Equity
0.32 0.41 0.44 0.52 0.79 0.80 0.66 0.33 0.00 0.00 0.00
Financial Leverage
-0.07 -0.05 -0.02 0.01 0.06 0.09 -0.02 -0.28 -0.56 -0.54 -0.59
Leverage Ratio
1.72 1.89 2.00 2.12 2.19 2.12 1.79 1.50 1.26 1.25 1.24
Compound Leverage Factor
1.77 1.97 1.69 1.06 -1.26 2.72 1.87 1.85 1.25 1.22 1.22
Debt to Total Capital
26.38% 29.02% 32.22% 34.40% 44.02% 44.48% 39.63% 24.70% 0.20% 0.21% 0.25%
Short-Term Debt to Total Capital
2.53% 0.00% 2.37% 0.00% 0.00% 0.00% 0.00% 0.00% 0.06% 0.05% 0.04%
Long-Term Debt to Total Capital
23.85% 29.02% 29.85% 34.40% 44.02% 44.48% 39.63% 24.70% 0.14% 0.17% 0.21%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
73.62% 70.98% 67.78% 65.60% 55.98% 55.52% 60.37% 75.30% 99.80% 99.79% 99.75%
Debt to EBITDA
2.96 -257.68 3.16 2.51 5.42 -22.27 -0.81 -24.33 -0.01 0.09 -0.03
Net Debt to EBITDA
-0.73 28.91 -0.33 0.05 0.02 -4.07 -0.07 4.66 3.92 -23.09 7.14
Long-Term Debt to EBITDA
2.67 -257.68 2.93 2.51 5.42 -22.27 -0.81 -24.33 -0.01 0.07 -0.03
Debt to NOPAT
3.85 5.62 1.39 3.99 20.33 -10.83 -0.99 -5.48 -0.01 -0.09 -0.03
Net Debt to NOPAT
-0.95 -0.63 -0.14 0.08 0.07 -1.98 -0.09 1.05 4.08 23.60 7.04
Long-Term Debt to NOPAT
3.48 5.62 1.29 3.99 20.33 -10.83 -0.99 -5.48 -0.01 -0.07 -0.03
Altman Z-Score
2.68 2.22 1.61 2.13 1.10 0.57 -0.95 1.07 4.50 3.76 5.04
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
3.98 3.24 2.59 2.90 4.00 4.03 3.25 2.66 3.49 3.34 3.30
Quick Ratio
2.49 1.99 1.72 1.86 2.87 2.67 2.11 1.90 2.80 2.68 2.68
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
11 -43 90 25 25 18 33 -586 -9.81 0.73 -111
Operating Cash Flow to CapEx
396.86% 220.82% 440.92% 174.06% 0.00% -72.51% -298.23% 159.15% -1,212.20% 145.94% 664.70%
Free Cash Flow to Firm to Interest Expense
0.99 -3.66 7.85 0.86 0.99 0.81 1.52 -30.12 -44.17 1.57 -155.26
Operating Cash Flow to Interest Expense
5.78 5.24 9.43 2.39 1.74 -0.34 -1.75 1.80 -107.41 34.03 58.84
Operating Cash Flow Less CapEx to Interest Expense
4.32 2.87 7.29 1.02 1.85 -0.80 -2.34 0.67 -116.27 10.71 49.99
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.58 0.57 0.64 0.65 0.53 0.49 0.47 0.44 0.40 0.52 0.42
Accounts Receivable Turnover
5.49 4.97 4.81 5.09 5.27 5.66 6.15 6.06 6.17 8.70 9.36
Inventory Turnover
1.71 1.72 2.03 2.15 1.86 1.80 2.52 3.04 2.57 4.32 4.26
Fixed Asset Turnover
6.18 5.90 6.24 7.07 6.44 5.38 6.56 6.53 4.73 6.03 4.68
Accounts Payable Turnover
9.62 8.08 7.94 8.73 9.46 8.58 7.75 8.21 7.54 12.44 9.58
Days Sales Outstanding (DSO)
66.49 73.42 75.87 71.69 69.22 64.51 59.33 60.25 59.17 41.93 38.98
Days Inventory Outstanding (DIO)
213.88 212.73 180.01 169.53 195.92 202.22 144.89 120.26 142.00 84.58 85.73
Days Payable Outstanding (DPO)
37.93 45.19 45.99 41.80 38.58 42.55 47.11 44.44 48.41 29.33 38.10
Cash Conversion Cycle (CCC)
242.44 240.96 209.90 199.42 226.56 224.18 157.11 136.07 152.76 97.18 86.61
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
702 642 550 442 409 418 464 787 252 326 343
Invested Capital Turnover
1.07 1.12 1.30 1.37 1.10 0.95 0.87 0.92 1.15 1.43 1.25
Increase / (Decrease) in Invested Capital
61 92 107 33 -8.76 -46 -323 536 -74 -17 56
Enterprise Value (EV)
1,453 1,717 927 1,443 862 773 380 665 841 458 1,013
Market Capitalization
1,522 1,748 955 1,438 861 718 354 717 1,184 842 1,403
Book Value per Share
$13.58 $11.94 $11.24 $8.67 $8.23 $7.66 $9.16 $17.39 $14.64 $17.45 $18.37
Tangible Book Value per Share
$9.63 $7.34 $7.23 $4.39 $3.63 $2.68 $3.52 $3.38 $10.37 $11.43 $11.55
Total Capital
1,047 947 852 667 729 675 725 1,116 596 716 741
Total Debt
276 275 275 229 321 300 287 276 1.19 1.53 1.85
Total Long-Term Debt
250 275 254 229 321 300 287 276 0.83 1.19 1.53
Net Debt
-68 -31 -28 4.79 1.06 55 26 -53 -343 -384 -390
Capital Expenditures (CapEx)
16 28 25 39 -2.70 10 13 22 1.97 11 6.33
Debt-free, Cash-free Net Working Capital (DFCFNWC)
254 182 128 136 120 112 99 44 14 -5.04 -4.35
Debt-free Net Working Capital (DFNWC)
599 488 431 360 440 358 360 373 358 380 388
Net Working Capital (NWC)
572 488 411 360 440 358 360 373 358 380 387
Net Nonoperating Expense (NNE)
-1.98 79 30 31 24 51 116 1.09 38 16 11
Net Nonoperating Obligations (NNO)
-68 -31 -28 4.79 1.06 44 26 -53 -343 -389 -396
Total Depreciation and Amortization (D&A)
26 26 27 40 44 47 62 61 33 40 25
Debt-free, Cash-free Net Working Capital to Revenue
35.44% 27.38% 19.84% 23.24% 26.47% 26.82% 18.22% 9.35% 4.26% -1.06% -1.11%
Debt-free Net Working Capital to Revenue
83.47% 73.26% 66.73% 61.75% 96.94% 85.29% 66.42% 78.38% 108.04% 79.71% 98.65%
Net Working Capital to Revenue
79.78% 73.26% 63.61% 61.75% 96.94% 85.29% 66.42% 78.38% 107.93% 79.64% 98.57%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$1.31 ($0.56) $3.35 $0.53 ($0.17) ($1.66) ($8.63) ($1.01) ($3.11) ($0.80) ($1.70)
Adjusted Weighted Average Basic Shares Outstanding
56.43M 53.77M 49.91M 49.07M 48.36M 47.48M 47.15M 44.17M 39.34M 39.74M 39.35M
Adjusted Diluted Earnings per Share
$1.23 ($0.56) $2.71 $0.49 ($0.17) ($1.66) ($8.63) ($1.01) ($3.11) ($0.80) ($1.70)
Adjusted Weighted Average Diluted Shares Outstanding
61.60M 53.77M 65.61M 53.64M 48.36M 47.48M 47.15M 44.17M 39.34M 39.74M 39.35M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
57.94M 56.37M 51.66M 50.65M 49.72M 49.00M 48.04M 48.16M 40.60M 39.97M 40.36M
Normalized Net Operating Profit after Tax (NOPAT)
67 49 42 40 17 -20 -20 -29 -32 -13 -32
Normalized NOPAT Margin
9.28% 7.35% 6.53% 6.81% 3.69% -4.87% -3.72% -6.05% -9.50% -2.70% -8.20%
Pre Tax Income Margin
9.60% -4.25% 7.89% 4.40% -1.86% -18.59% -80.03% -18.71% -35.94% -4.75% -19.94%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
6.06 -2.31 5.24 1.82 0.60 -2.74 -19.31 -3.69 -541.27 -50.07 -110.78
NOPAT to Interest Expense
6.49 4.16 17.15 2.03 0.64 -1.25 -13.52 -2.59 -378.89 -35.05 -77.55
EBIT Less CapEx to Interest Expense
4.61 -4.68 3.10 0.45 0.70 -3.20 -19.90 -4.82 -550.13 -73.39 -119.63
NOPAT Less CapEx to Interest Expense
5.04 1.79 15.02 0.66 0.75 -1.72 -14.10 -3.72 -387.75 -58.37 -86.40
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -2.81% -5.58% -10.94% -27.85% 0.00%

Quarterly Metrics And Ratios for Veeco Instruments

This table displays calculated financial ratios and metrics derived from Veeco Instruments' official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 3/31/2025 12/31/2024 9/30/2024 6/30/2024 3/31/2024 12/31/2023 9/30/2023 6/30/2023 3/31/2023 12/31/2022 9/30/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
-4.12% 4.72% 4.20% 8.81% 13.67% 13.09% 3.17% -1.44% -1.87% 0.54% 14.42%
EBITDA Growth
-32.37% -66.97% 7.15% 130.72% 76.27% 52.76% 19.03% -493.21% -29.08% -25.56% -8.92%
EBIT Growth
-35.82% -83.96% 9.31% 120.05% 124.81% 80.58% 26.75% -750.42% -40.63% -24.03% 6.99%
NOPAT Growth
-46.73% -38.40% -10.87% 52.78% 122.46% -85.17% 40.29% -21.15% -40.70% 587.80% 10.36%
Net Income Growth
-45.33% -30.84% -10.67% 117.52% 150.02% -83.22% 63.38% -983.69% -34.43% 1,471.57% 67.25%
EPS Growth
-45.95% -45.65% -14.29% 115.53% 117.65% -77.23% 55.56% -994.44% -29.17% 1,246.67% 58.82%
Operating Cash Flow Growth
113.57% -3.73% 149.70% -24.62% -32.74% -10.95% -85.06% 231.77% -43.85% 93.70% 57.77%
Free Cash Flow Firm Growth
46.18% 32.56% 71.02% 44.09% 55.99% -281.65% -3,914.07% -320.94% -547.61% 429.54% 169.30%
Invested Capital Growth
6.37% 9.48% 10.94% 14.22% 13.47% 16.76% 42.39% 29.30% 31.62% 24.21% 3.02%
Revenue Q/Q Growth
-8.15% -1.45% 5.08% 0.80% 0.32% -1.94% 9.73% 5.30% -0.19% -10.54% 4.83%
EBITDA Q/Q Growth
90.91% -66.95% 30.32% -17.76% -6.75% 7.20% 137.37% -571.89% -19.19% -16.46% 23.43%
EBIT Q/Q Growth
264.73% -84.06% 45.53% -24.15% -8.84% 8.62% 126.69% -950.53% -26.78% -23.75% 36.97%
NOPAT Q/Q Growth
-15.37% -38.47% 47.99% -30.87% -2.13% -10.97% 153.66% 0.65% -93.47% 742.10% 42.56%
Net Income Q/Q Growth
-20.17% -31.83% 46.89% -31.62% 1.00% -11.95% 128.80% -1,076.09% -93.22% 757.10% 55.78%
EPS Q/Q Growth
-20.00% -30.56% 44.00% -32.43% -19.57% 9.52% 126.09% -1,047.06% -91.58% 648.15% 50.00%
Operating Cash Flow Q/Q Growth
-29.57% 61.15% 108.33% -9.68% -68.25% 317.99% -37.11% -19.41% -57.96% -29.86% 1,296.18%
Free Cash Flow Firm Q/Q Growth
34.46% -0.01% 32.80% -22.17% 17.87% 57.03% -29.67% 3.85% -439.03% 802.34% 114.31%
Invested Capital Q/Q Growth
0.84% 0.15% 2.33% 2.93% 3.79% 1.48% 5.35% 2.25% 6.80% 23.77% -4.33%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
40.93% 40.62% 42.86% 42.86% 43.22% 45.22% 43.34% 41.77% 40.40% 40.91% 40.69%
EBITDA Margin
11.62% 5.59% 16.67% 13.44% 16.47% 17.72% 16.21% -47.61% 10.62% 13.12% 14.05%
Operating Margin
8.46% 2.13% 13.17% 9.51% 12.63% 13.90% 12.55% 8.47% 6.39% 8.71% 10.22%
EBIT Margin
8.46% 2.13% 13.17% 9.51% 12.63% 13.90% 12.55% -51.60% 6.39% 8.71% 10.22%
Profit (Net Income) Margin
7.14% 8.22% 11.88% 8.50% 12.52% 12.44% 13.86% -52.78% 5.69% 83.82% 8.75%
Tax Burden Percent
79.73% 343.63% 89.02% 87.54% 96.06% 89.47% 109.17% 101.53% 97.08% 1,089.37% 98.64%
Interest Burden Percent
105.91% 112.27% 101.33% 102.09% 103.20% 100.00% 101.11% 100.76% 91.82% 88.37% 86.82%
Effective Tax Rate
20.27% -243.63% 10.98% 12.46% 3.94% 10.53% -9.17% 0.00% 2.92% -989.37% 1.36%
Return on Invested Capital (ROIC)
6.97% 7.81% 12.47% 9.09% 13.32% 13.92% 16.46% 7.14% 7.72% 123.58% 14.86%
ROIC Less NNEP Spread (ROIC-NNEP)
5.91% 4.51% 11.46% 7.63% 6.75% 13.92% 10.71% -607.67% 4.16% 267.93% 329.17%
Return on Net Nonoperating Assets (RNNOA)
-0.49% -0.31% -0.47% -0.24% -0.11% -0.66% -0.09% -18.15% 0.18% -6.20% -0.55%
Return on Equity (ROE)
6.47% 7.50% 11.99% 8.84% 13.21% 13.26% 16.37% -11.02% 7.91% 117.37% 14.32%
Cash Return on Invested Capital (CROIC)
2.81% 1.62% 1.50% -0.55% -3.43% -7.24% -27.28% -18.39% 9.10% 18.21% 11.86%
Operating Return on Assets (OROA)
4.78% 1.23% 7.41% 5.42% 7.23% 7.86% 7.23% -30.83% 3.94% 5.55% 6.61%
Return on Assets (ROA)
4.04% 4.75% 6.69% 4.84% 7.17% 7.03% 7.99% -31.54% 3.51% 53.43% 5.66%
Return on Common Equity (ROCE)
6.47% 7.50% 11.99% 8.84% 13.21% 13.26% 16.37% -11.02% 7.91% 117.37% 14.32%
Return on Equity Simple (ROE_SIMPLE)
7.86% 0.00% 10.77% 11.61% -2.51% 0.00% 11.93% 11.00% 27.73% 0.00% 10.48%
Net Operating Profit after Tax (NOPAT)
11 13 22 15 21 22 24 9.58 9.52 146 17
NOPAT Margin
6.74% 7.32% 11.72% 8.32% 12.14% 12.44% 13.70% 5.93% 6.20% 94.86% 10.08%
Net Nonoperating Expense Percent (NNEP)
1.06% 3.30% 1.00% 1.45% 6.57% 0.00% 5.75% 614.81% 3.56% -144.35% -314.30%
Return On Investment Capital (ROIC_SIMPLE)
1.06% 1.27% - - - 2.28% - - - 17.11% -
Cost of Revenue to Revenue
59.07% 59.38% 57.14% 57.14% 56.78% 54.78% 56.66% 58.23% 59.60% 59.09% 59.31%
SG&A Expenses to Revenue
14.96% 13.77% 13.69% 13.98% 14.16% 13.51% 12.86% 14.74% 14.74% 13.63% 12.88%
R&D to Revenue
17.04% 16.99% 17.43% 18.02% 16.99% 16.73% 16.25% 16.94% 17.96% 17.12% 15.77%
Operating Expenses to Revenue
32.47% 38.49% 29.69% 33.36% 30.59% 31.32% 30.79% 33.30% 34.01% 32.20% 30.47%
Earnings before Interest and Taxes (EBIT)
14 3.88 24 17 22 24 22 -83 9.81 13 18
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
19 10 31 24 29 31 29 -77 16 20 24
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
1.43 1.97 2.52 3.70 2.88 2.60 2.46 2.17 1.86 1.65 2.14
Price to Tangible Book Value (P/TBV)
1.98 2.78 3.82 5.75 4.60 4.23 4.13 3.80 3.41 2.57 4.05
Price to Revenue (P/Rev)
1.64 2.12 2.65 3.77 2.88 2.62 2.45 2.07 1.70 1.48 1.46
Price to Earnings (P/E)
18.23 20.64 23.40 31.87 0.00 0.00 20.59 19.70 6.72 5.72 20.38
Dividend Yield
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield
5.48% 4.84% 4.27% 3.14% 0.00% 0.00% 4.86% 5.08% 14.87% 17.47% 4.91%
Enterprise Value to Invested Capital (EV/IC)
1.50 2.07 2.62 3.82 2.94 2.68 2.49 2.19 1.86 1.69 2.13
Enterprise Value to Revenue (EV/Rev)
1.49 2.03 2.59 3.73 2.85 2.58 2.43 2.05 1.70 1.44 1.46
Enterprise Value to EBITDA (EV/EBITDA)
12.61 15.56 16.10 23.36 18.07 0.00 18.41 16.28 13.63 10.67 10.07
Enterprise Value to EBIT (EV/EBIT)
17.94 21.70 21.04 30.70 23.85 0.00 26.57 24.15 20.40 15.38 14.64
Enterprise Value to NOPAT (EV/NOPAT)
17.17 20.26 23.20 32.00 34.06 35.08 37.96 34.50 5.81 4.70 14.56
Enterprise Value to Operating Cash Flow (EV/OCF)
14.24 22.77 28.29 48.13 34.31 27.85 24.07 12.47 11.20 8.55 10.22
Enterprise Value to Free Cash Flow (EV/FCFF)
54.86 133.35 184.06 0.00 0.00 0.00 0.00 0.00 23.25 10.27 18.22
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.31 0.36 0.37 0.39 0.40 0.41 0.43 0.45 0.44 0.48 0.62
Long-Term Debt to Equity
0.31 0.32 0.33 0.35 0.36 0.41 0.43 0.45 0.44 0.44 0.58
Financial Leverage
-0.08 -0.07 -0.04 -0.03 -0.02 -0.05 -0.01 0.03 0.04 -0.02 0.00
Leverage Ratio
1.68 1.72 1.81 1.86 1.89 1.89 2.07 2.08 2.11 2.00 2.28
Compound Leverage Factor
1.77 1.93 1.84 1.89 1.95 1.89 2.09 2.09 1.94 1.76 1.98
Debt to Total Capital
23.54% 26.38% 26.98% 27.82% 28.58% 29.02% 29.88% 30.93% 30.31% 32.22% 38.35%
Short-Term Debt to Total Capital
0.00% 2.53% 2.59% 2.67% 2.74% 0.00% 0.00% 0.00% 0.00% 2.37% 2.82%
Long-Term Debt to Total Capital
23.54% 23.85% 24.39% 25.15% 25.83% 29.02% 29.88% 30.93% 30.31% 29.85% 35.54%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
76.46% 73.62% 73.02% 72.18% 71.42% 70.98% 70.12% 69.07% 69.69% 67.78% 61.65%
Debt to EBITDA
2.97 2.96 2.42 2.46 2.54 -257.68 3.22 3.40 3.18 3.16 2.92
Net Debt to EBITDA
-1.23 -0.73 -0.40 -0.26 -0.20 28.91 -0.14 -0.15 0.02 -0.33 0.03
Long-Term Debt to EBITDA
2.97 2.67 2.19 2.22 2.29 -257.68 3.22 3.40 3.18 2.93 2.71
Debt to NOPAT
4.05 3.85 3.49 3.37 4.78 5.62 6.63 7.20 1.35 1.39 4.23
Net Debt to NOPAT
-1.68 -0.95 -0.57 -0.36 -0.38 -0.63 -0.30 -0.33 0.01 -0.14 0.04
Long-Term Debt to NOPAT
4.05 3.48 3.15 3.05 4.33 5.62 6.63 7.20 1.35 1.29 3.92
Altman Z-Score
2.18 2.52 2.76 3.60 2.68 2.36 1.97 1.35 1.50 1.47 1.31
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
4.44 3.98 3.54 3.52 3.05 3.24 2.69 2.51 2.41 2.59 2.50
Quick Ratio
2.80 2.49 2.25 2.14 1.87 1.99 1.64 1.55 1.46 1.72 1.71
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-31 -48 -47 -71 -58 -70 -164 -126 -131 39 4.30
Operating Cash Flow to CapEx
295.96% 548.08% 441.34% 286.32% 236.57% 275.59% 110.30% 288.35% 200.37% 1,168.69% 743.27%
Free Cash Flow to Firm to Interest Expense
-12.42 -17.09 -16.49 -25.55 -22.09 -22.97 -59.02 -41.42 -45.73 13.45 1.49
Operating Cash Flow to Interest Expense
7.98 10.21 6.11 3.06 3.57 9.62 2.54 3.68 4.84 11.48 16.36
Operating Cash Flow Less CapEx to Interest Expense
5.28 8.35 4.73 1.99 2.06 6.13 0.24 2.40 2.43 10.50 14.16
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
0.57 0.58 0.56 0.57 0.57 0.57 0.58 0.60 0.62 0.64 0.65
Accounts Receivable Turnover
4.92 5.49 4.50 4.97 4.93 4.97 3.98 4.35 4.89 4.81 4.50
Inventory Turnover
1.66 1.71 1.62 1.61 1.66 1.72 1.71 1.80 1.90 2.03 2.13
Fixed Asset Turnover
6.20 6.18 6.14 6.22 6.02 5.90 5.70 5.91 5.92 6.24 6.38
Accounts Payable Turnover
7.39 9.62 7.08 7.18 6.71 8.08 6.61 6.86 6.50 7.94 7.63
Days Sales Outstanding (DSO)
74.23 66.49 81.07 73.47 73.99 73.42 91.69 83.97 74.59 75.87 81.19
Days Inventory Outstanding (DIO)
219.73 213.88 225.26 226.02 220.05 212.73 212.93 202.99 192.35 180.01 171.73
Days Payable Outstanding (DPO)
49.42 37.93 51.52 50.81 54.42 45.19 55.24 53.18 56.13 45.99 47.83
Cash Conversion Cycle (CCC)
244.54 242.44 254.82 248.68 239.62 240.96 249.38 233.79 210.81 209.90 205.09
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
708 702 701 685 666 642 632 600 587 550 444
Invested Capital Turnover
1.03 1.07 1.06 1.09 1.10 1.12 1.20 1.20 1.25 1.30 1.48
Increase / (Decrease) in Invested Capital
42 61 69 85 79 92 188 136 141 107 13
Enterprise Value (EV)
1,060 1,453 1,836 2,616 1,960 1,717 1,572 1,315 1,093 927 945
Market Capitalization
1,163 1,522 1,881 2,646 1,982 1,748 1,584 1,327 1,092 955 942
Book Value per Share
$14.01 $13.58 $13.15 $12.62 $12.29 $11.94 $11.44 $11.85 $11.33 $11.24 $8.58
Tangible Book Value per Share
$10.16 $9.63 $8.68 $8.12 $7.70 $7.34 $6.81 $6.76 $6.20 $7.23 $4.53
Total Capital
1,062 1,047 1,022 991 963 947 919 887 840 852 716
Total Debt
250 276 276 276 275 275 275 274 255 275 274
Total Long-Term Debt
250 250 249 249 249 275 275 274 255 254 254
Net Debt
-104 -68 -45 -30 -22 -31 -12 -13 1.35 -28 2.89
Capital Expenditures (CapEx)
6.76 5.18 3.99 2.95 3.96 11 6.40 3.89 6.95 2.83 6.35
Debt-free, Cash-free Net Working Capital (DFCFNWC)
262 254 251 236 211 182 166 140 123 128 138
Debt-free Net Working Capital (DFNWC)
616 599 572 541 508 488 453 427 376 431 410
Net Working Capital (NWC)
616 572 546 514 482 488 453 427 376 411 390
Net Nonoperating Expense (NNE)
-0.67 -1.64 -0.29 -0.31 -0.68 0.00 -0.27 95 0.78 17 2.28
Net Nonoperating Obligations (NNO)
-104 -68 -45 -30 -22 -31 -12 -13 1.35 -28 2.89
Total Depreciation and Amortization (D&A)
5.29 6.30 6.48 6.92 6.70 6.64 6.49 6.45 6.50 6.79 6.59
Debt-free, Cash-free Net Working Capital to Revenue
36.96% 35.44% 35.43% 33.57% 30.66% 27.38% 25.70% 21.85% 19.08% 19.84% 21.41%
Debt-free Net Working Capital to Revenue
86.74% 83.47% 80.71% 77.06% 73.89% 73.26% 70.09% 66.61% 58.47% 66.73% 63.48%
Net Working Capital to Revenue
86.74% 79.78% 76.97% 73.29% 70.05% 73.26% 70.09% 66.61% 58.47% 63.61% 60.36%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.21 $0.26 $0.39 $0.27 $0.39 $0.44 $0.44 ($1.61) $0.17 $2.59 $0.30
Adjusted Weighted Average Basic Shares Outstanding
57.75M 56.43M 56.41M 56.28M 55.97M 53.77M 55.35M 52.86M 50.56M 49.91M 49.89M
Adjusted Diluted Earnings per Share
$0.20 $0.25 $0.36 $0.25 $0.37 $0.46 $0.42 ($1.61) $0.17 $2.02 $0.27
Adjusted Weighted Average Diluted Shares Outstanding
60.23M 61.60M 62.65M 62.54M 60.76M 53.77M 59.64M 52.86M 59.86M 65.61M 65.15M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
58.29M 57.94M 56.78M 56.78M 56.64M 56.37M 56.34M 56.35M 51.69M 51.66M 51.43M
Normalized Net Operating Profit after Tax (NOPAT)
11 2.72 22 15 21 22 16 9.58 9.52 9.37 17
Normalized NOPAT Margin
6.74% 1.49% 11.72% 8.32% 12.14% 12.44% 8.79% 5.93% 6.20% 6.10% 10.08%
Pre Tax Income Margin
8.96% 2.39% 13.34% 9.71% 13.04% 13.90% 12.69% -51.99% 5.87% 7.69% 8.87%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
5.65 1.40 8.45 6.05 8.42 7.89 8.02 -27.33 3.41 4.64 6.09
NOPAT to Interest Expense
4.50 4.80 7.52 5.29 8.09 7.06 8.75 3.14 3.31 50.59 6.00
EBIT Less CapEx to Interest Expense
2.95 -0.47 7.06 4.98 6.91 4.40 5.71 -28.60 0.99 3.66 3.89
NOPAT Less CapEx to Interest Expense
1.81 2.93 6.13 4.22 6.57 3.57 6.45 1.86 0.90 49.60 3.80
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Frequently Asked Questions About Veeco Instruments' Financials

When does Veeco Instruments's fiscal year end?

According to the most recent income statement we have on file, Veeco Instruments' financial year ends in December. Their financial year 2024 ended on December 31, 2024.

How has Veeco Instruments' net income changed over the last 10 years?

Veeco Instruments' net income appears to be on a downward trend, with a most recent value of $73.71 million in 2024, falling from -$66.94 million in 2014. The previous period was -$30.37 million in 2023. See Veeco Instruments' forecast for analyst expectations on what’s next for the company.

What is Veeco Instruments's operating income?
Veeco Instruments's total operating income in 2024 was $66.98 million, based on the following breakdown:
  • Total Gross Profit: $304.01 million
  • Total Operating Expenses: $237.02 million
How has Veeco Instruments revenue changed over the last 10 years?

Over the last 10 years, Veeco Instruments' total revenue changed from $392.87 million in 2014 to $717.30 million in 2024, a change of 82.6%.

How much debt does Veeco Instruments have?

Veeco Instruments' total liabilities were at $480.81 million at the end of 2024, a 13.6% decrease from 2023, and a 152.4% increase since 2014.

How much cash does Veeco Instruments have?

In the past 10 years, Veeco Instruments' cash and equivalents has ranged from $119.75 million in 2021 to $279.74 million in 2017, and is currently $145.60 million as of their latest financial filing in 2024.

How has Veeco Instruments' book value per share changed over the last 10 years?

Over the last 10 years, Veeco Instruments' book value per share changed from 18.37 in 2014 to 13.58 in 2024, a change of -26.1%.



This page (NASDAQ:VECO) was last updated on 5/25/2025 by MarketBeat.com Staff
From Our Partners